ImmuneSpec employee Elisa will help shape the scientific strategy, strengthen data analysis and bioinformatics approaches, support team development, and work directly with clients across immunology and translational projects.

Public source

Publisher name

Public post

๐—œ๐—บ๐—บ๐˜‚๐—ป๐—ฒ๐—ฆ๐—ฝ๐—ฒ๐—ฐ ๐—ถ๐˜€ ๐˜€๐˜๐—ฟ๐—ฒ๐—ป๐—ด๐˜๐—ต๐—ฒ๐—ป๐—ถ๐—ป๐—ด ๐—ถ๐˜๐˜€ ๐˜€๐—ฐ๐—ถ๐—ฒ๐—ป๐˜๐—ถ๐—ณ๐—ถ๐—ฐ ๐—น๐—ฒ๐—ฎ๐—ฑ๐—ฒ๐—ฟ๐˜€๐—ต๐—ถ๐—ฝ. ๐——๐—ฟ. ๐—˜๐—น๐—ถ๐˜€๐—ฎ ๐—ฅ๐—ผ๐˜€๐—ฎ๐˜๐—ถ ๐—ฆ๐—ฐ๐—ฎ๐—น๐—ฐ๐—ต๐—ถ ๐—ต๐—ฎ๐˜€ ๐—ท๐—ผ๐—ถ๐—ป๐—ฒ๐—ฑ ๏ฟฝโ€ฆ

Log in to read the full post

Company

ImmuneSpec

Excellence in immunopeptidomics for better, safer biotherapeutics.

Industry
Biotechnology Research
Location
Niel, BE
Company size
11โ€“50 employees

About ImmuneSpec

ImmuneSpec is a next-generation immunopeptidomics platform that delivers unmatched precision in identifying peptides presented by MHC molecules. Powered by advanced mass spectrometry, ImmuneSpec provides deep, unbiased insight into immune presentationโ€”enabling the development of safer, more effective biotherapeutics. The platform supports early detection of immunogenic regions in biologics, reducing immune risk and guiding safer drug design. ImmuneSpec also accelerates target discovery by revealing rare neoepitopes and validates constructs by confirming that designed epitopes are effectively presented. With rapid turnaround, high-throughput capability, and rigorous quality control, ImmuneSpec empowers researchers to advance transformative therapiesโ€”from personalized medicine to next-generation vaccines and immunotherapies.

See more

Latest activity

2 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

ยฉ 2026 SeedOpsCompany intelligence.

SeedOps.